Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Advanced Malignant Solid Tumors 3

Interventions

vorolanib 3neratinib 3toripalimab 1dacomitinib 1Vinorelbine 1TAK-243 1Premedication 1Paclitaxel 1Injections 1Immune Checkpoint Inhibitors 1Clinical Trials, Phase II as Topic 1Capecitabine 11-(4-(4-(3-oxa-8-azabicyclo(3.2.1)octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-4-yl)urea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Advanced Malignant Solid Tumors × vorolanib × Other solid neoplasm × Clear all
NCT03792958 2022-11-14

Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors

AnewPharma

Phase 1 Unknown
19 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04328506 2021-11-26

Bioequivalency Study of CM082 Tablet in Healthy Volunteers

AnewPharma

Phase 1 Completed
96 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04126668 2020-05-21

A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

AnewPharma

Phase 1 Completed
24 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡